3D Communications is preeminent in preparing pharmaceutical, biotech and device companies for regulatory meetings with the FDA, EMA, and other regulatory agencies. It has just announced that it will expand its healthcare globally.
Breaking News
A webinar on Regulatory And Procedural Aspects Of Applications For Type I Variations is released by EMA.
Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by India's GVK Biosciences, French watchdog ANSM said on Friday.
